# A Phase I Study of BKM120 and Everolimus in Advanced Solid Malignancies

> **NCT01470209** · PHASE1 · COMPLETED · sponsor: **Emory University** · enrollment: 43 (actual)

## Conditions studied

- Solid Tumors
- Lung Cancer

## Interventions

- **DRUG:** BKM120
- **DRUG:** Everolimus

## Key facts

- **NCT ID:** NCT01470209
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2017-05
- **Final completion:** 2017-05
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2018-03-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01470209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01470209, "A Phase I Study of BKM120 and Everolimus in Advanced Solid Malignancies". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01470209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*